XML 56 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share - Summary (Details) - USD ($)
$ / shares in Units, shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Numerator:        
Net loss attributable to Surgery Partners, Inc. $ (25,000,000.0) $ (22,900,000) $ (31,200,000) $ (70,800,000)
Less: Amounts attributable to participating securities 0 0 0 (10,300,000)
Net loss attributable to common stockholders, basic (25,000,000.0) (22,900,000) (31,200,000) (81,100,000)
Net loss attributable to common stockholders, diluted $ (25,000,000.0) $ (22,900,000) $ (31,200,000) $ (81,100,000)
Denominator:        
Weighted average shares outstanding- basic (shares) 88,907 80,726 88,604 68,350
Weighted average shares outstanding- diluted (shares) [1] 88,907 80,726 88,604 68,350
Loss per share:        
Basic (in USD per share) $ (0.28) $ (0.28) $ (0.35) $ (1.19)
Diluted (in USD per share) [1] $ (0.28) $ (0.28) $ (0.35) $ (1.19)
Stock options        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 1,323 1,974 1,527 1,927
Restricted shares        
Loss per share:        
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive (shares) 604 1,461 669 1,444
[1] The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive.